- 全部删除
您的购物车当前为空
Mobocertinib (tak788) 是可口服的EGFR 和HER2突变的抑制剂,具有抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Mobocertinib (tak788) 是可口服的EGFR 和HER2突变的抑制剂,具有抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 127 | In stock | |
| 5 mg | ¥ 189 | In stock | |
| 10 mg | ¥ 297 | In stock | |
| 25 mg | ¥ 596 | In stock | |
| 50 mg | ¥ 953 | In stock | |
| 100 mg | ¥ 1,530 | In stock | |
| 200 mg | ¥ 2,330 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 243 | In stock |
Mobocertinib 相关产品
| 产品描述 | Mobocertinib (tak788) is a potent inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent |
| 靶点活性 | EGFR (WT):35 nM (IC50) |
| 别名 | tak788 |
| 分子量 | 585.7 |
| 分子式 | C32H39N7O4 |
| CAS No. | 1847461-43-1 |
| Smiles | COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1ncc(C(=O)OC(C)C)c(n1)-c1cn(C)c2ccccc12 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 5.86 mg/mL (10.01 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容